BISLERI-S IV INJECTION 100MG/5ML DISPOSIBLE • Cumulative target dose: 120

•      Cumulative target dose: 120 to 150mg/kg over the full treatment course (typically 4 to 6 months)

•      Not suitable for patients with severe upper limb weakness who cannot bear weight through the arms

Keep the bottle tightly closed and protect from light

●     Serious (rare): Liver damage

•      Swallow tablets whole with water

BISLERI-S IV INJECTION 100MG/5ML DISPOSIBLE • Cumulative target dose: 120BISLERI S IV INJECTION 100MG 5ML ONLINE AT BEST PRICE IN PAKISTAN GENERIC: Iron Sucrose 100mg 5ml (20mg ml) Intravenous Solution MANUFACTURER: Sami Pharmaceuticals (Pvt) Ltd QUANTITY: 5 ampoules per pack INDICATION Bisleri S IV Injection 100mg 5ml is an intravenous iron preparation indicated for the treatment of iron deficiency anemia in patients where oral iron therapy is insufficient, not tolerated, or not feasible. It is particularly indicated in